Nobel Biocare, the world leader in innovative esthetic dental solutions, has announced it will contribute $2.5 million to the UCLA School of Dentistry to create an endowed chair in surgical implant dentistry. The Chair will promote education and training of students, faculty as well as national and international dental practitioners.
"Since the 1960's Nobel Biocare has set the industry standard developing state-of-the art, esthetic dental implant technologies. But, creating innovative products alone does not guarantee patients will receive long-lasting, beautiful smiles. Dentists must be properly trained to best integrate the latest implant solutions into their practices," said Heliane Canepa, President and CEO of Nobel Biocare. "That is why Nobel Biocare is committed to working with world-leading dental schools like UCLA to develop research, education and training programs that help dentists around the world deliver patients beautiful teeth now - and for the long term."
The occupant of the endowed chair will be a worldwide leader in implant dentistry education and research, deeply involved in the training of undergraduate and graduate students, faculty members, and practitioners both nationally and internationally.
"This endowment is a very important and exciting development for the section of Oral & Maxillofacial Surgery, the division of Diagnostic & Surgical Sciences, and the School as a whole," said Dr. No-Hee Park, Dean of the UCLA School of Dentistry. "The Nobel Biocare Endowed Chair in Surgical Implant Dentistry is a wonderful way to advance the teaching and research activities of a leading scholar while helping to strengthen UCLA's position at the forefront of dental education."
This initiative is an extension of an ongoing collaboration between Nobel Biocare and UCLA School of Dentistry, which dates back to 1984 when UCLA was one of the first dental schools to introduce education and research programs in implant dentistry.
